Hypoalbuminemia as a Predictor of Outcomes in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.19166/med.v14i2.9548Keywords:
Acute myeloid leukemia, Albumin, Level, MarkerAbstract
Background : In acute myeloid leukemia (AML), hypoalbuminemia has been observed at diagnosis and during treatment, often correlating with poor clinical outcomes such as reduced remission rates, increased treatment-related toxicity, and shorter overall survival (OS). This systematic review and meta-analysis aim to investigate the prognostic value of hypoalbuminemia in patients with AML.
Methods : A comprehensive literature search was conducted across PubMed, EMBASE, and Scopus to identify relevant studies published up to January 5, 2025. The search strategy included a combination of Medical Subject Headings (MeSH) terms and keywords such as “hypoalbuminemia,” “acute myeloid leukemia,” “AML,” “serum albumin,” “prognosis,” and “outcomes.” Boolean operators (AND, OR) were applied to refine the search.
Result : This systematic review and meta-analysis included 10 studies with a total sample size of 4,105 participants, of which 2,134 were male, comparing normal albumin levels to hypoalbuminemia across diverse populations. The meta-analysis comparing OS between AML patients with hypoalbuminemia and normal serum albumin levels shows a pooled HR of 1.08 (95% CI: 0.81–1.44).
Conclusions : While this meta-analysis suggests a potential association between hypoalbuminemia and poorer OS and DFS in AML patients, the lack of statistical significance and high heterogeneity caution against definitive conclusions.
References
1. Vakiti A, Reynolds SB, Mewawalla P. Acute Myeloid Leukemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan 16]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK507875/
2. Prassek VV, Rothenberg-Thurley M, Sauerland MC, Herold T, Janke H, Ksienzyk B, et al. Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older. Haematologica. 2018 Nov;103(11):1853–61. https://doi.org/10.3324/haematol.2018.191536
3. Gounden V, Vashisht R, Jialal I. Hypoalbuminemia. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan 16]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK526080/
4. Doucette K, Percival ME, Williams L, Kandahari A, Taylor A, Wang S, et al. Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia. Hematol Oncol. 2021 Dec;39(5):697–706. https://doi.org/10.1002/hon.2925
5. Skar ET, Wendelbo Ø, Reikvam H. The prognostic impact of C‐reactive protein and albumin in patients diagnosed with acute myeloid leukaemia. eJHaem. 2024 Dec;5(6):1223–35. https://doi.org/10.1002/jha2.1022
6. Wang N, Desai A, Ge B, Li W, Jin X, Bai H, et al. Prognostic value of hypoalbuminemia at diagnosis in de novo non-M3 acute myeloid leukemia. Leukemia & Lymphoma. 2020 Feb 23;61(3):641–9. https://doi.org/10.1080/10428194.2019.1686499
7. Fox AD, Okereke C, Le T, Jillella AP, Bryan LJ, Anwar T, et al. Serum Albumin As a Prognostic Factor for Overall Survival at 6-Months in Acute Myeloid Leukemia (AML). Blood. 2021 Nov 5;138(Supplement 1):1226–1226. https://doi.org/10.1182/blood-2021-154138
8. Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, et al. Severe Hypoalbuminemia at Day 90 Predicts Worse Nonrelapse Mortality and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 2011 Mar;17(3):384–93. https://doi.org/10.1016/j.bbmt.2010.07.011
9. Chen J, Hui Y, Zhai Y, Yang M, Zhang X, Mi Y, et al. Serum albumin is associated with the inherent property of acute myeloid leukemia and correlates with patient outcomes. Blood Sci. 2024 Apr;6(2):e00189. https://doi.org/10.1097/bs9.0000000000000189
10. Sivgin S, Baldane S, Ozenmis T, Keklik M, Kaynar L, Kurnaz F, et al. The impact of pretransplant hypoalbuminemia on survival in patients with leukemia who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT): a nutritional problem? Transplant Proc. 2013 Nov;45(9):3371–4. https://doi.org/10.1016/j.transproceed.2013.02.144
11. Xiao Z, Li H, Xiao D, Liu Y, Chen X, Luo S, et al. Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: a retrospective cohort study. BMC Cancer. 2022 Nov 3;22(1):1127. https://doi.org/10.1186/s12885-022-10231-0
12. Murthy HS, Sheets K, Kumar A, Nishihori T, Mina A, Chavez JC, et al. Hypoalbuminemia at Day +90 Is Associated with Inferior Nonrelapse Mortality and Overall Survival in Allogeneic Hematopoietic Cell Transplantation Recipients: A Confirmatory Study. Biology of Blood and Marrow Transplantation. 2018 Feb;24(2):400–5. https://doi.org/10.1016/j.bbmt.2017.09.022
13. Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, et al. The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. Haematologica. 2016 Nov;101(11):1426–33. https://doi.org/10.3324/haematol.2016.145847
14. Yanagisawa H, Kawabata H, Ueda Y, Arita K, Iwao-Kawanami H, Sakai T, et al. Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes. Int J Hematol. 2022 Jul;116(1):81–8. https://doi.org/10.1007/s12185-022-03321-z
15. Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181–93. https://doi.org/10.1002/jpen.1451
16. Gremese E, Bruno D, Varriano V, Perniola S, Petricca L, Ferraccioli G. Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. JCM. 2023 Sep 17;12(18):6017. https://doi.org/10.3390/jcm12186017
17. Tang J, Wang L, Luo J, Xi D, Huang W, Yang S, et al. Early albumin level and mortality in hemodialysis patients: a retrospective study. Ann Palliat Med. 2021 Oct;10(10):10697–705. https://doi.org/10.21037/apm-21-2611
18. Jäntti T, Tarvasmäki T, Harjola VP, Parissis J, Pulkki K, Javanainen T, et al. Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock. Den Uil C, editor. PLoS ONE. 2019 May 16;14(5):e0217006. https://doi.org/10.1371/journal.pone.0217006
19. Christina NM, Tjahyanto T, Lie JG, Santoso TA, Albertus H, Octavianus D, et al. Hypoalbuminemia and colorectal cancer patients: Any correlation?: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Feb 22;102(8):e32938. https://doi.org/10.1097/MD.0000000000032938
20. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–7. https://doi.org/10.1111/j.0894-0959.2004.17603.x
21. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003 Mar;237(3):319–34. https://doi.org/10.1097/01.sla.0000055547.93484.87
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Christin Yosefin Jacobs, Fajar Prianto Nugroho, Sesa Amelia, Davin Pannaausten, Annisa Naufal Almaszahra, Andi Bagus Prayogo, Jessica, Jimmy Angga Pranata
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
